Study: Cannabidiol Mitigates Parkinson’s Disease Symptoms

By Paul Armentano, NORML

The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, controls sleep disorders in patients with Parkinson’s diseasemmjplant (PD), according to a series of case summaries published in the Journal of Clinical Pharmacy and Therapeutics.

An international team of investigators from the University of Sao Paulo, Brazil and the University of Minnesota Medical School reported on the ingestion of CBD by four Parkinson’s disease patients with REM sleep behavior disorder (RBD) – a condition characterized by nightmares and active behavior during dreaming.

Read moreStudy: Cannabidiol Mitigates Parkinson’s Disease Symptoms